Using western blot and immunochemistry staining, BTG3 expression was reduced in ovarian carcinoma, compared with ovarian normal tissue and benign tumor, indicating that down-regulated BTG3 expression contributes to ovarian epithelial carcinogenesis. The gene discussed is BTG3; the disease is benign neoplasm.